Associate Clinical Professor of Medicine, University Pennsylvania
Hematology
Dr. Arthur P. Staddon, MD
|
|
Give Review
Arthur P. Staddon, MD is an expert in the field of Hematology. He graduated from Perelman School of Medicine at the University of Pennsylvania. He has 4 awards "America's Top Doctors", "Philadelphia Magazine", "America's Top Doctors for Cancer" and "Super Doctor". Arthur Staddon has written publications. He has 20 publications published with PubMed. The lastest paper is: 'Agranulocytosis associated with yohimbine use.' Arthur Staddon accepts Medicare payments and is registered with Medicare.gov.
Publications
- SARC009: Phase 2 study of dasatinib in patients With previously treated, high-grade, advanced sarcoma.
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic LipoSarcoma or LeiomyoSarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Rando...
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients With recurrent or refractory rhabdomyosarcoma, osteo...
- Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related Sarcomas.
- Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim Analysis of an open-label, parallel-group, phase ...
- Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic Sarcomas in pa...
- Results of a phase I dose escalation study of eltrombopag in patients With advanced soft tissue sarcoma receiving doxorubicin and ifosfamide.
- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas.
- Early Outcomes for Malignant Peripheral Nerve Sheath Tumor Treated With Chemotherapy.
- Treatment of adult rhabdomyoSarcoma.
- Promising survival in patients with recurrent non-small cell lung Cancer treated with docetaxel and gemcitabine in combination as second-line therapy.
- Phospho-S6 ribosomal protein: a potential new predictive Sarcoma marker for targeted mTOR therapy.
- Osteogenic sarcoma presenting With lung metastasis.
- Agranulocytosis Associated with yohimbine use.
- Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients.
- Phase II trial of oral rubitecan in previously treated pancreatic Cancer patients.
- Denosumab in patients With giant-cell tumour of bone: an open-label, phase 2 study.
- Improved survival after pulmonary metastasectomy for soft tissue Sarcoma.
- Effect of trabectedin on the QT interval in patients With advanced solid tumor malignancies.
Schools
Univ Of Pa Sch Of Med
University Pa Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- America's Top Doctors for Cancer
- Super Doctor
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Hospital of the University of Pennsylvania -
Pennsylvania Hospital
Drug Facts
| NPI NUMBER | 1588658942 | |
| NPPES Provider LastName | STADDON | |
| NPPES Provider FirstName | ARTHUR | |
| NPPES Provider ZIPCode | 191063500 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 501.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 45.0 | |
| Percent Opioid Claims | 8.98 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588658942 |
| Last Name Of The Provider | STADDON |
| First Name Of The Provider | ARTHUR |
| View All |
Similar Doctors
|
|
Dr. Ingrid F. Kohut, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Henry III, MD |
|
|
Dr. Bernard A. Mason, MD |
|
|
Dr. Lee P. Hartner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Mintzer, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|